Anthem Biosciences Ltd.

NSE: ANTHEM | BSE: 544449 | ISIN: INE0CZ201020 | Industry: Pharmaceuticals
|
648.4000 10.65 (1.67%)
NSE Mar 18, 2026 15:31 PM
Volume: 78,816
 

648.40
1.67%
Hem Securities
manufacturing. Company is one of the few companies in India with integrated New Chemical Entity (NCE) and New Biological Entity (NBE) capabilities across drug discovery,...
BOB Capital Markets Ltd. released a Buy report for Anthem Biosciences Ltd. with a price target of 835.0 on 27 Feb, 2026.
More from Anthem Biosciences Ltd.
Recommended